Dr David Alan Timm, MD | |
308 Highland Blvd, Natchez, MS 39120-4611 | |
(601) 442-7676 | |
(601) 442-9590 |
Full Name | Dr David Alan Timm |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 308 Highland Blvd, Natchez, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023194867 | NPI | - | NPPES |
1349011 | Medicaid | LA | |
00114041 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 016299 (Louisiana) | Secondary |
208000000X | Pediatrics | 10207 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr David Alan Timm, MD 308 Highland Blvd, Natchez, MS 39120-4611 Ph: (601) 442-7676 | Dr David Alan Timm, MD 308 Highland Blvd, Natchez, MS 39120-4611 Ph: (601) 442-7676 |
News Archive
Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.
Along with the release of a WHO-UNICEF guide on medicines for children, the U.N. agencies on Friday said the guide "exposed dangerous shortfalls" in medicines designed for children and called for more research into treating children, Reuters reports. "While effective medicines exist to fight disease and treat life-threatening conditions like malnutrition, formulations suitable for children are often difficult to source," Francisco Blanco, UNICEF's chief of medicines and nutrition, said, according to the news service.
Research published yesterday indicates that recurrence of human papillomavirus (HPV)-induced cancers affecting the oropharynx (the area of the throat just behind the mouth) can be predicted by blood and saliva tests that screen for DNA fragments from HPV that have been shed by cancer cells.
Mylan Inc. today announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash. Bioniche Pharma will provide Mylan not only an immediate entry into the North American injectables market but also a platform for future growth opportunities. This transaction is expected to be accretive to Mylan's earnings in year one, without accounting for any operational or other synergies.
› Verified 3 days ago
Dr. Danita Ronique Weary, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 136 Jefferson Davis Blvd, Natchez, MS 39120 Phone: 601-442-5439 Fax: 601-442-3755 | |
Dr. Tommie Brian Stretch, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 Sergeant Prentiss Dr, Suite 7, Natchez, MS 39120 Phone: 601-445-9543 Fax: 601-445-9803 | |
Dr. Jennifer Vermaelen Russ, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 136 Jefferson Davis Blvd, Natchez, MS 39120 Phone: 601-442-5439 Fax: 601-442-3755 |